psilocybin has been researched along with Acute Post-Traumatic Stress Disorder in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 11 (78.57) | 2.80 |
| Authors | Studies |
|---|---|
| Malcolm, B; Sarparast, A; Stauffer, CS; Thomas, K | 1 |
| Benedek, DM; Canales, JJ; Eri, R; Johnson, LR; Marathe, PA; Raut, SB; Ravindran, M; Ursano, RJ; van Eijk, L | 1 |
| Bradley, E; Khan, AJ; O'Donovan, A; Woolley, J | 1 |
| Aaronson, ST; Barber, GS | 1 |
| Agin-Liebes, G; Feduccia, A; Grinsell, N; Paradise, S; Price, CM; Rabin, DM | 1 |
| Armstrong, SB; Davis, AK; Lancelotta, RL; Levin, AW; Nagib, PB | 1 |
| Haridy, R | 1 |
| Nogrady, B | 1 |
| Guan, P; Han, S; Wen, L; Xu, D; Xu, S; Yang, Y; Zhu, C | 1 |
| Tullis, P | 1 |
| Bird, CIV; Modlin, NL; Rucker, JJH | 1 |
| Sessa, B | 1 |
| Check, E | 1 |
| Fellner, CH | 1 |
7 review(s) available for psilocybin and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.
Topics: Adult; Drug Interactions; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychotherapy; Stress Disorders, Post-Traumatic | 2022 |
Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.
Topics: Cannabinoids; Fear; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Stress Disorders, Post-Traumatic; United States | 2022 |
Psilocybin for Trauma-Related Disorders.
Topics: Hallucinogens; Humans; Psilocybin; Psychotherapy; Stress Disorders, Post-Traumatic | 2022 |
The Emerging Field of Psychedelic Psychotherapy.
Topics: Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychotherapy; Stress Disorders, Post-Traumatic | 2022 |
The need for establishing best practices and gold standards in psychedelic medicine.
Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Health; Psilocybin; Stress Disorders, Post-Traumatic | 2023 |
Psilocybin and MDMA for the treatment of trauma-related psychopathology.
Topics: Depressive Disorder, Major; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Stress Disorders, Post-Traumatic; Treatment Outcome | 2021 |
The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.
Topics: Animals; Data Collection; Emotions; Forecasting; Hallucinogens; Humans; Mental Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Stress Disorders, Post-Traumatic | 2018 |
7 other study(ies) available for psilocybin and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD.
Topics: Humans; Pilot Projects; Psilocybin; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans | 2023 |
Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.
Topics: Australia; Depression; Drug Approval; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Stress Disorders, Post-Traumatic; Time Factors | 2023 |
Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics.
Topics: Australia; Depression; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Stress Disorders, Post-Traumatic | 2023 |
Integrating Unified Medical Language System and Kleinberg's Burst Detection Algorithm into Research Topics of Medications for Post-Traumatic Stress Disorder.
Topics: Algorithms; Hallucinogens; Humans; Medication Therapy Management; Psilocybin; Stress Disorders, Post-Traumatic; Unified Medical Language System | 2020 |
How ecstasy and psilocybin are shaking up psychiatry.
Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resistant; Drug Prescriptions; Efficiency; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Neuronal Plasticity; Niacin; Psilocybin; Psychiatry; Psychotherapy; Rumination, Cognitive; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic | 2021 |
Psychedelic drugs: the ups and downs of ecstasy.
Topics: Agaricales; Animals; Anxiety; Brain; Cactaceae; Controlled Clinical Trials as Topic; Female; Hallucinogens; History, 20th Century; History, 21st Century; Humans; Lysergic Acid Diethylamide; Medicine, Traditional; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; Phytotherapy; Pilot Projects; Psilocybin; Psychotherapy; Stress Disorders, Post-Traumatic | 2004 |
Post-traumatic neurosis--theme and variations.
Topics: Accidents, Occupational; Adult; Humans; Hypnosis; Male; Middle Aged; Occupational Medicine; Psilocybin; Psychotherapy; Stress Disorders, Post-Traumatic | 1968 |